INNOVATIVE EYEWEAR, INC. Operating Expenses
INNOVATIVE EYEWEAR, INC. (LUCY) reported Operating Expenses of $1.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. operating expenses for the quarter ending 2026-06-30 was $1.95M, a 9.77% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. operating expenses for the quarter ending 2026-03-31 was $2.55M, a 19.91% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. operating expenses for the quarter ending 2025-12-31 was $2.61M, a 15.34% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. operating expenses for the quarter ending 2025-09-30 was $2.17M, a 18.90% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. operating expenses for fiscal 2025 was $9.06M, a 11.35% increase from fiscal 2024.
- INNOVATIVE EYEWEAR, INC. operating expenses for fiscal 2024 was $8.14M, a 20.82% increase from fiscal 2023.
- INNOVATIVE EYEWEAR, INC. operating expenses for fiscal 2023 was $6.74M, a 22.02% increase from fiscal 2022.
- INNOVATIVE EYEWEAR, INC. operating expenses for fiscal 2022 was $5.52M, a 64.62% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.95M 10-Q · filed 2026-08-14 | $4.49M 10-Q · filed 2026-08-14 | $7.11M derived: sum of 3 quarters · filed 2026-08-14 | $9.27M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $2.55M 10-Q · filed 2026-05-14 | $5.16M derived: sum of 2 quarters · filed 2026-05-14 | $7.33M derived: sum of 3 quarters · filed 2026-05-14 | $9.49M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $4.78M derived: sum of 2 quarters · filed 2026-03-25 | $6.94M derived: sum of 3 quarters · filed 2026-08-14 | $9.06M 10-K · filed 2026-03-25 |
| 2025-09-30 | $2.17M 10-Q · filed 2025-11-13 | $4.32M derived: sum of 2 quarters · filed 2026-08-14 | $6.45M 10-Q · filed 2025-11-13 | $8.71M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $2.16M 10-Q · filed 2026-08-14 | $4.28M 10-Q · filed 2026-08-14 | $6.55M derived: sum of 3 quarters · filed 2026-08-14 | $8.37M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.12M 10-Q · filed 2026-05-14 | $4.39M derived: sum of 2 quarters · filed 2026-05-14 | $6.21M derived: sum of 3 quarters · filed 2026-05-14 | $8.24M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $4.09M derived: sum of 2 quarters · filed 2026-03-25 | $6.12M derived: sum of 3 quarters · filed 2026-03-25 | $8.14M 10-K · filed 2026-03-25 |
| 2024-09-30 | $1.82M 10-Q · filed 2025-11-13 | $3.85M derived: sum of 2 quarters · filed 2025-11-13 | $5.87M 10-Q · filed 2025-11-13 | $8.19M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $2.03M 10-Q · filed 2025-08-14 | $4.05M 10-Q · filed 2025-08-14 | $6.37M derived: sum of 3 quarters · filed 2025-08-14 | $8.04M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $2.02M 10-Q · filed 2025-05-13 | $4.34M derived: sum of 2 quarters · filed 2025-05-13 | $6.01M derived: sum of 3 quarters · filed 2025-05-13 | $7.32M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $3.99M derived: sum of 2 quarters · filed 2025-03-24 | $5.30M derived: sum of 3 quarters · filed 2025-03-24 | $6.74M 10-K · filed 2025-03-24 |
| 2023-09-30 | $1.68M 10-Q · filed 2024-11-12 | $2.98M derived: sum of 2 quarters · filed 2024-11-12 | $4.42M 10-Q · filed 2024-11-12 | $6.10M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.30M 10-Q · filed 2024-08-12 | $2.74M 10-Q · filed 2024-08-12 | $4.42M derived: sum of 3 quarters · filed 2024-08-12 | $5.81M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $1.44M 10-Q · filed 2024-05-14 | $3.12M derived: sum of 2 quarters · filed 2024-05-14 | $4.51M derived: sum of 3 quarters · filed 2024-05-14 | $5.70M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $3.07M derived: sum of 2 quarters · filed 2024-03-25 | $4.26M derived: sum of 3 quarters · filed 2024-03-25 | $5.52M 10-K · filed 2024-03-25 |
| 2022-09-30 | $1.39M 10-Q · filed 2023-11-14 | $2.58M derived: sum of 2 quarters · filed 2023-11-14 | $3.84M 10-Q · filed 2023-11-14 | $5.29M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.19M 10-Q · filed 2023-08-11 | $2.45M 10-Q · filed 2023-08-11 | $3.90M derived: sum of 3 quarters · filed 2023-08-11 | $5.03M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $1.26M 10-Q · filed 2023-05-12 | $2.71M derived: sum of 2 quarters · filed 2023-05-12 | $3.84M derived: sum of 3 quarters · filed 2023-05-12 | $4.39M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $2.58M derived: sum of 2 quarters · filed 2023-03-24 | $3.13M derived: sum of 3 quarters · filed 2023-03-24 | $3.35M 10-K · filed 2023-03-24 |
| 2021-09-30 | $1.13M 10-Q · filed 2022-11-10 | $1.68M derived: sum of 2 quarters · filed 2022-11-10 | $1.91M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $550.46K 10-Q · filed 2022-09-26 | $776.16K 10-Q · filed 2022-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |